Literature DB >> 9501269

Oligosaccharide excretion in adult Gaucher disease.

J G de Jong1, J M Aerts, S van Weely, C E Hollak, J van Pelt, L M van Woerkom, M L Liebrand-van Sambeek, R A Wevers.   

Abstract

Gaucher disease is a lysosomal storage disease characterized by storage of glucocerebroside due to lysosomal glucocerebrosidase deficiency. Increased urinary excretion of sialyloligosaccharides and mannosylglycoasparagines has been described for two patients with the infantile form of the disease, probably as a consequence of obstruction of lysosomal functioning due to the glycolipid accumulation in lysosomes. By thin-layer chromatography, we found increased urinary oligosaccharide excretion in a series of adult non-neuronopathic patients. Oligosaccharide patterns were comparable between patients and also with the pattern observed in infantile Gaucher disease. Composition was analysed by methanolysis and gas chromatography. Mannose and N-acetylglucosamine are the main carbohydrates in all oligosaccharide bands. A statistically significant correlation was found between oligosaccharide excretion and the severity of the disease expressed as severity score index. Patients treated with enzyme replacement therapy showed a reduction up to 65% of the original oligosaccharide excretion after 1 year of treatment, comparable with the reduction in spleen volume.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501269     DOI: 10.1023/a:1005311430722

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

1.  Glycoprotein storage in Gaucher disease: lectin histochemistry and biochemical studies.

Authors:  R DeGasperi; J Alroy; R Richard; V Goyal; U Orgad; R E Lee; C D Warren
Journal:  Lab Invest       Date:  1990-09       Impact factor: 5.662

Review 2.  Pathogenesis of lysosomal storage disorders as illustrated by Gaucher disease.

Authors:  J M Aerts; S Van Weely; R Boot; C E Hollak; J M Tager
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Primary structure of three mannosyl-glycoasparagines and nine sialyl-oligosaccharides isolated from the urine of two patients with Gaucher's disease (infantile form).

Authors:  J C Michalski; J Montreuil; G Strecker; H van Halbeek; L Dorland; J F Vliegenthart; B Cartigny; J P Farriaux
Journal:  Eur J Biochem       Date:  1983-05-02

4.  A method for the rapid detection of urinary glycopeptides in alpha-N-acetylgalactosaminidase deficiency and other lysosomal storage diseases.

Authors:  D Schindler; T Kanzaki; R J Desnick
Journal:  Clin Chim Acta       Date:  1990-09       Impact factor: 3.786

5.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Authors:  N W Barton; R O Brady; J M Dambrosia; A M Di Bisceglie; S H Doppelt; S C Hill; H J Mankin; G J Murray; R I Parker; C E Argoff
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

6.  DNA mutation analysis of Gaucher patients.

Authors:  E Sidransky; S Tsuji; B M Martin; B Stubblefield; E I Ginns
Journal:  Am J Med Genet       Date:  1992-02-01

7.  Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients.

Authors:  A Zimran; A Kay; T Gelbart; P Garver; D Thurston; A Saven; E Beutler
Journal:  Medicine (Baltimore)       Date:  1992-11       Impact factor: 1.889

8.  Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.

Authors:  S Van Weely; M B Van Leeuwen; I D Jansen; M A De Bruijn; E M Brouwer-Kelder; A W Schram; M C Sa Miranda; J A Barranger; E M Petersen; J Goldblatt
Journal:  Biochim Biophys Acta       Date:  1991-06-05

9.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Authors:  C E Hollak; S van Weely; M H van Oers; J M Aerts
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

Authors:  A Sibille; C M Eng; S J Kim; G Pastores; G A Grabowski
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

View more
  1 in total

1.  A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder.

Authors:  Y Liu; R Wada; H Kawai; K Sango; C Deng; T Tai; M P McDonald; K Araujo; J N Crawley; U Bierfreund; K Sandhoff; K Suzuki; R L Proia
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.